Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Aqeilan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Trends in Immunology|May 17, 2025
Causes and consequences of T cell DNA damageCostas Koufaris, Michael Berger, Rami Aqeilan
Future Oncology (London, England)|February 12, 2010
WWOX gene and gene product: tumor suppression through specific protein interactionsZaidoun Salah, Rami Aqeilan, Kay Huebner
Hematology/Oncology Clinics of North America|August 25, 2004
Tcl1 as a model for lymphomagenesisYuri Pekarsky, Nicola Zanesi, Rami Aqeilan, et al.
The Biochemical Journal|October 31, 2002
Mechanism of action of interleukin-2 (IL-2)-Bax, an apoptosis-inducing chimaeric protein targeted against cells expressing the IL-2 receptorRami Aqeilan, Rotem Kedar, Ahmi Ben-Yehudah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric proteinAhmi Ben-Yehudah, Rami Aqeilan, Dana Robashkevich, et al.
Biochemical and Biophysical Research Communications|January 10, 2002
Utilizing chimeric proteins for exploring the cellular fate of endogenous proteinsAhmi Ben-Yehudah, Rami Aqeilan, Ruth Belostotsky, et al.
Expert Review of Endocrinology & Metabolism|February 5, 2025
Safety and efficacy of umbilical cord mesenchymal stem cells in the treatment of type 1 and type 2 diabetes mellitus: a systematic review and meta-analysisAhmed Hosney Nada, Ismail A Ibrahim, Vittorio Oteri, et al.
Molecular Biology of the Cell|October 15, 2010
Cell death or survival promoted by alternative isoforms of ErbB4Maria Sundvall, Ville Veikkolainen, Kari Kurppa, et al.
International Journal of Experimental Pathology|September 30, 2005
Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injuryMichael J Segel, Rami Aqeilan, Keren Zilka, et al.
Scientific Reports|January 10, 2018
Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanismLiat Peretz, Elazar Besser, Renana Hajbi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Trends in Immunology|May 17, 2025
Causes and consequences of T cell DNA damageCostas Koufaris, Michael Berger, Rami Aqeilan
Future Oncology (London, England)|February 12, 2010
WWOX gene and gene product: tumor suppression through specific protein interactionsZaidoun Salah, Rami Aqeilan, Kay Huebner
Hematology/Oncology Clinics of North America|August 25, 2004
Tcl1 as a model for lymphomagenesisYuri Pekarsky, Nicola Zanesi, Rami Aqeilan, et al.
The Biochemical Journal|October 31, 2002
Mechanism of action of interleukin-2 (IL-2)-Bax, an apoptosis-inducing chimaeric protein targeted against cells expressing the IL-2 receptorRami Aqeilan, Rotem Kedar, Ahmi Ben-Yehudah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric proteinAhmi Ben-Yehudah, Rami Aqeilan, Dana Robashkevich, et al.
Biochemical and Biophysical Research Communications|January 10, 2002
Utilizing chimeric proteins for exploring the cellular fate of endogenous proteinsAhmi Ben-Yehudah, Rami Aqeilan, Ruth Belostotsky, et al.
Expert Review of Endocrinology & Metabolism|February 5, 2025
Safety and efficacy of umbilical cord mesenchymal stem cells in the treatment of type 1 and type 2 diabetes mellitus: a systematic review and meta-analysisAhmed Hosney Nada, Ismail A Ibrahim, Vittorio Oteri, et al.
Molecular Biology of the Cell|October 15, 2010
Cell death or survival promoted by alternative isoforms of ErbB4Maria Sundvall, Ville Veikkolainen, Kari Kurppa, et al.
International Journal of Experimental Pathology|September 30, 2005
Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injuryMichael J Segel, Rami Aqeilan, Keren Zilka, et al.
Scientific Reports|January 10, 2018
Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanismLiat Peretz, Elazar Besser, Renana Hajbi, et al.
Pageof 2